Trans American Aquaculture (GRPS) Net Margin (2023 - 2024)
Trans American Aquaculture (GRPS) reported Net Margin of 10092.35% for Q4 2024, down 952871.0% on a YoY basis from N/an in Q1 2024, and down 53.35% quarter-over-quarter from 6581.21% in Q2 2024.
Trans American Aquaculture (GRPS) Net Margin (2023 - 2024) Analysis & Trends
Trans American Aquaculture has reported Net Margin for 2 years, with the latest figure at 10092.35% in Q4 2024.
- For the quarter ending Q4 2024, Net Margin fell 952871.0% year-over-year to 10092.35%; the trailing twelve-month figure through Sep 2025 stood at 13058.33% (down 1264078.0% YoY), and the FY2024 full-year result was 846.96%, up 101867.0% from the prior year.
- Net Margin for Q4 2024 stood at 10092.35%, down from 6581.21% in the prior quarter.
- The five-year high for Net Margin was 84.44% in Q1 2024, with the low at 10092.35% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | Trans American Aquaculture | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -10,092.35% |
| Jun 30, 2024 | -6,581.21% |
| Mar 31, 2024 | -84.44% |
| Dec 31, 2023 | -563.64% |